Document Detail

Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
MedLine Citation:
PMID:  15115568     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Assessment of amino acid clearances by continuous venovenous hemodialysis with filtration in treatment of a metabolic decompensation in acute maple syrup urine disease. DESIGN: Single patient assessment. SETTING: Pediatric intensive care unit. PATIENTS: A 10-yr-old male with known maple syrup urine disease (branched chain alpha-ketoacid dehydrogenase deficiency) with metabolic decompensation due to an acute viral illness, characterized by altered mental status, progressive obtundation, and severe acidosis. INTERVENTIONS: Continuous venovenous hemodialysis with filtration. MEASUREMENTS AND MAIN RESULTS: Continuous venovenous hemodialysis with filtration was instituted with both filtration (500 mL/m(2)/hr) and dialysis (1000 mL/m(2)/hr) utilized, allowing rapid correction of systemic ketoacidosis while providing amino acid clearance. Amino acid clearance was measured at initiation and at 24 hrs into therapy. The procedure was well tolerated, with near normal mental status within 12 hrs and resumption of enteral feedings. During the 24-hr period of continuous venovenous hemodialysis with filtration, serum leucine levels fell from 2352 to 381 micromoles/L, isoleucine fell from 626 to 164, and valine fell from 1117 to 228. Leucine, isoleucine, and valine clearance rates averaged 13.1, 12.8, and 13.2 mL/min, respectively, and were constant during the 24 hrs of treatment. Clearance of other amino acids during this period did not vary significantly between cationic, anionic, neutral, or hydrophobic amino acids. CONCLUSIONS: Continuous venovenous hemodialysis with filtration provides an effective therapeutic alternative to intermittent hemodialysis during acute metabolic decompensation in maple syrup urine disease.
Stanley Paul Hmiel; Rick A Martin; Michael Landt; Fiona H Levy; Dorothy K Grange
Related Documents :
8155818 - Metabolic pathways of 1-butyl [3-13c]acrylate. identification of urinary metabolites in...
3126358 - Urinary d-4-hydroxyphenyllactate, d-phenyllactate and d-2-hydroxyisocaproate, abnormali...
7460478 - Kinetics of single doses of fenbufen in patients with renal insufficiency.
22989818 - Omega-3 fatty acids in the prevention of atrial fibrillation recurrences after cardiove...
1276478 - Distribution of phospholipids, fatty acids, and platelet factor 3 activity among subcel...
24898228 - Health benefits of plant-derived α-linolenic acid.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies     Volume:  5     ISSN:  1529-7535     ISO Abbreviation:  Pediatr Crit Care Med     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-04-29     Completed Date:  2004-10-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  100954653     Medline TA:  Pediatr Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  278-81     Citation Subset:  IM    
Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Amino Acids / metabolism
Leucine / blood*
Maple Syrup Urine Disease / blood*,  therapy*
Time Factors
Reg. No./Substance:
0/Amino Acids; 61-90-5/Leucine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Jading in the pediatric intensive care unit: Implications for healthcare providers of medically comp...
Next Document:  Adrenoceptor agonist poisoning after accidental oral ingestion of brimonidine eye drops.